Jiajoyce R. Conway, DNP, CRNP, AOCNP

Subcutaneous power ports seem to rarely function properly when administering irinotecan but function properly when the regimen changes. Is there an explanation for why this happens?

Is there a standard process for administering KCL through an IV?

Given reservoir volume and catheter length, 2.2 mL of Cathflo does not seem to be enough volume to reach the tip, thus the sheath/clot. Are there any reports of using larger volumes?

Is there a new consensus about wearing personal protective equipment (PPE) when handling monoclonal antibodies (MABs) for infusion?

How can clinicians be more informed about the carcinogenicity of drugs they prescribe?

Oncology nurses must anticipate a disciplinary crossover between oncology and obstetrics to care for this unique subgroup of women with breast cancer.

How does substitution of chemotherapy agent affect the overall survival rate of oncology patients?

Managing anemia in patients with myelodysplastic syndrome (MDS) is complex. When are erythroid growth factors used as primary treatment?

What is the impact of nicotine use on the efficacy of chemotherapy? What information is important to discuss with patients who continue to smoke while on chemotherapy?

How soon should the creatinine be measured when dosing carboplatin (Paraplatin)?